The Latest Breaking News from Obesity

Around 61% of U.S. adults are expected to have some type of cardiovascular disease within the next 30 years, according to a recent report from the American Heart Association.

Those with BMI of 35 and a comorbidity could be prescribed tirzepatide and Nice says it is more effective than Wegovy

Living with obesity for 10 years is associated with an up to 60% increase in the risk of these conditions, scientists said.

Intermittent fasting, where people eat what they want, but only during certain daily windows of time, has skyrocketed in popularity in recent years

Research has shown that screen time inhibits young children's ability to read faces and learn social skills... let's look a little deeper

The iconic documentary turned 20 this month — the same month Oprah and "South Park" released weight loss specials

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes. Read further on Dynamite News:

South Park: The End Of Obesity about Ozempic has finally landed on Paramount+ and it's bonkers. Here are the top 9 mind-blowing moments.

In the "End of Obesity" special, South Park residents want the latest semaglutides, but there's a cheaper option